title: NZB serum factor (NZB-SF)-B precursor cell maturation factor. II. In vivo effects of NZB-SF or mAb against NZB-SF on B lineage cell populations.
abstract: In vivo effects of NZB serum factor (NZB-SF), which enhances the maturation of B precursor cells in vitro, were examined. Immunoaffinity-purified NZB-SF from young NZB mice was injected into B6 mice intraperitoneally twice weekly, five times total (5 micrograms/dose/mouse). Control mice were given 0.01% albumin. Then the B lineage cell populations defined phenotypically (sIg+ cells, B220+ cells, and AA4.1+ cells) or the numbers of colony-forming B lineage cells were examined. NZB-SF-treated B6 mice exhibited a decrease in the percentage of B precursor cells in marrow, even though the percentage of sIg+ cells in marrow or spleen did not differ from controls. In contrast, the frequency of colony-forming B cells in marrow and spleen, especially sIg- colony-forming B cells in marrow, increased significantly in NZB-SF-treated mice as compared to controls. In addition, monoclonal antibody (mAb) against NZB-SF was injected weekly for 9 weeks into NZB mice beginning at 7 weeks of age. mAb vs NZB-SF at a dose of 5 micrograms per mouse per injection, as stated above, prevented the decline of sIg- colony-forming B lineage cells which usually occurred in the adult NZB mice (greater than 16 weeks). This treatment also prevented, in part, the decline of the B220+ cell population which normally occurs in the marrow with increasing age. Thus NZB-SF impressively influences the composition of B lineage cell populations in normal B6 mice and may account for abnormal changes of B lineage cell populations observed in NZB mice.
authors.affiliation: Department of Pediatrics, University of South Florida/All Children's Hospital, St. Petersburg 33701.
authors.forename: H
authors.initials: H
authors.lastname: Jyonouchi
authors.forename: R M
authors.initials: RM
authors.lastname: Voss
authors.forename: R A
authors.initials: RA
authors.lastname: Good
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D000943:Antigens, Differentiation / Q000032:analysis; D001402:B-Lymphocytes / Q000187:drug effects* / Q000502:physiology; D001790:Blood Physiological Phenomena; D018956:CD5 Antigens; D006410:Hematopoiesis / Q000187:drug effects*; D051379:Mice; D008814:Mice, Inbred NZB / Q000097:blood*; D008815:Mice, Inbred Strains; D010641:Phenotype
chemical_list: D000911:Antibodies, Monoclonal; D000943:Antigens, Differentiation; D018956:CD5 Antigens